Neoadjuvant 4AC-4THP
RF of response to NAC in HER2- BC
NAC in ER+ HER/Neu- BC
HER2+ BC Therapy
Biomarker Dynamics in Breast Cancer Post-NAC
Breast cancer patterns in Iraq
Inter-observer reproducibility of the residual CBI
New trends in adjuvant radiotherapy in BC
SLNB; safe staging post-NA setting
Immunopathological mechanisms in TNBC
